AARTIPHARMPharmaceuticals
Aarti Pharmalabs Ltd — Cash Flow Statement
₹591.95
-4.72%
Aarti Pharmalabs Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -112.32 Cr | 17.57 Cr | 130.46 Cr | -184.86 Cr | — |
| Issuance Of Capital Stock | 43000.00 | 0.00 | — | — | — |
| Capital Expenditure | -443.88 Cr | -198.79 Cr | -119.66 Cr | -141.15 Cr | — |
| End Cash Position | 6.73 Cr | 23.63 Cr | 12.12 Cr | 83.27 Cr | — |
| Beginning Cash Position | 23.63 Cr | 12.12 Cr | 83.27 Cr | 5.33 Cr | — |
| Changes In Cash | -16.90 Cr | 11.51 Cr | -71.15 Cr | 77.94 Cr | — |
| Financing Cash Flow | 65.44 Cr | 9.72 Cr | -163.46 Cr | 260.38 Cr | — |
| Interest Paid Cff | -24.51 Cr | -17.21 Cr | -21.05 Cr | -11.96 Cr | — |
| Cash Dividends Paid | -31.72 Cr | -18.13 Cr | -18.13 Cr | — | — |
| Net Common Stock Issuance | 43000.00 | 0.00 | — | — | — |
| Common Stock Issuance | 43000.00 | 0.00 | — | — | — |
| Net Issuance Payments Of Debt | 127.86 Cr | 49.99 Cr | -124.29 Cr | 272.34 Cr | — |
| Net Short Term Debt Issuance | 27.86 Cr | 49.99 Cr | -124.29 Cr | 272.34 Cr | — |
| Net Long Term Debt Issuance | 100.00 Cr | 0.00 | -124.29 Cr | 272.34 Cr | — |
| Investing Cash Flow | -413.90 Cr | -214.56 Cr | -157.80 Cr | -138.74 Cr | — |
| Net Other Investing Changes | 1000.00 | 0.55 Cr | -1000.00 | 0.03 Cr | — |
| Interest Received Cfi | 7.10 Cr | 3.04 Cr | 0.94 Cr | 76000.00 | — |
| Dividends Received Cfi | 0.05 Cr | 0.03 Cr | 0.04 Cr | 2.48 Cr | — |
| Net Investment Purchase And Sale | 22.83 Cr | -19.40 Cr | -39.12 Cr | -0.07 Cr | — |
| Net Intangibles Purchase And Sale | -41.84 Cr | -43.18 Cr | -17.53 Cr | — | — |
| Purchase Of Intangibles | -41.84 Cr | -43.18 Cr | -17.53 Cr | — | — |
| Net PPE Purchase And Sale | -402.04 Cr | -155.60 Cr | -102.13 Cr | -141.15 Cr | — |
| Purchase Of PPE | -402.04 Cr | -155.60 Cr | -102.13 Cr | -141.15 Cr | — |
| Operating Cash Flow | 331.56 Cr | 216.35 Cr | 250.12 Cr | -43.70 Cr | — |
| Taxes Refund Paid | -64.53 Cr | -56.94 Cr | -62.38 Cr | -21.13 Cr | — |
| Change In Working Capital | -86.07 Cr | -121.85 Cr | -31.63 Cr | -230.36 Cr | — |
| Change In Payable | -56.91 Cr | 43.35 Cr | 130.20 Cr | -71.86 Cr | — |
| Change In Inventory | 55.28 Cr | -39.66 Cr | -126.66 Cr | -55.99 Cr | — |
| Change In Receivables | -84.43 Cr | -125.54 Cr | -35.17 Cr | -102.51 Cr | — |
| Other Non Cash Items | 19.80 Cr | 14.17 Cr | 20.11 Cr | 12.81 Cr | — |
| Provisionand Write Offof Assets | 1.28 Cr | 1.07 Cr | 1.50 Cr | — | — |
| Depreciation And Amortization | 86.90 Cr | 73.24 Cr | 62.54 Cr | 42.12 Cr | — |
| Depreciation | 86.90 Cr | 73.24 Cr | 62.50 Cr | 42.12 Cr | — |
| Gain Loss On Investment Securities | -0.05 Cr | -0.03 Cr | -0.80 Cr | -2.52 Cr | — |
| Net Income From Continuing Operations | 360.69 Cr | 300.49 Cr | 260.77 Cr | 155.38 Cr | — |
| Net Other Financing Charges | — | -1000.00 | 0.01 Cr | — | — |
| Sale Of Investment | — | 0.55 Cr | — | 0.04 Cr | 0.00 |
| Purchase Of Investment | — | -19.40 Cr | -39.12 Cr | -0.11 Cr | 0.00 |
| Amortization Cash Flow | — | 1.27 Cr | 0.04 Cr | — | — |
| Gain Loss On Sale Of PPE | — | -0.55 Cr | — | — | — |
| Other Cash Adjustment Outside Changein Cash | — | — | 52000.00 | 16000.00 | — |
| Change In Other Current Assets | — | — | — | -0.03 Cr | 45960.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Aarti Pharmalabs Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.